Atlas FDA

NeoBase 2 Non-derivatized MSMS Kit

FDA 510(k) clearance K193103 · decided 2020-02-07

Clearance details

K-number
K193103
Device name
NeoBase 2 Non-derivatized MSMS Kit
Applicant
Perkinelmer, Inc.
Decision
Substantially Equivalent
Date received
2019-11-08
Decision date
2020-02-07
Days to decision
91 days
Clearance type
Traditional
Product code
NQL
Device class
2
Regulation number
862.1055
Medical specialty
Clinical Chemistry
Advisory committee
Clinical Chemistry
Location
Waltham, MA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Perkinelmer

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
NeoBase 2 Non-derivatized MSMS Kit (K173568)Wallac Oy, Subsidiary of Perkinelmer, Inc.2018-09-04
NEOBASE NON-DERIVATIZED MSMS KIT MODEL 3040-001U (K093916)Perkinelmer, Inc.2010-08-23
NEOBASE NON-DERIVATIZED MSMS KIT, MODEL 3040 (K083130)Perkinelmer, Inc.2009-07-09
NEOGRAM AMINO ACIDS AND ACYLCARNITINES TANDEM MASS SPECTROMETRY KIT, MODEL MS-8970 (DEN040002)Perkinelmer Life Sciences, Inc.2004-08-24

Recalls involving this device

No recalls on record reference this clearance.